Hopefully this doesn't get buried or blocked but I'm at the Blue place and actually posting there - and oh man is there plenty to say, cover, & discuss in healthcare, biopharma, and digital health/med tech given recent events. the-sy-guy (bksy) (social) https://t.co/RHOqt9Gb1U

Love a CBER head who says he embraces transparency, communication, and truth in public health (btw, over the years he's done this to hundreds of journalists and scientists, including many engaging in good faith on his brand of vaccine pseudoscience)

How are new breakthroughs shaping the future of Alzheimer’s research? Join us on Wednesday, January 29th at 12pm for a webinar hosted by the ADDF and @endpts, moderated by @the_sy_guy and featuring expert panelists. Register now: https://t.co/t90ClRa9W6.

Hopefully this doesn't get buried or blocked but I'm at the Blue place and actually posting there - and oh man is there plenty to say, cover, & discuss in healthcare, biopharma, and digital health/med tech given recent events. the-sy-guy (bksy) (social) https://t.co/RHOqt9Gb1U

A statement from Los Angeles Times Guild leadership:

Um, no. Here are the facts about who capped insulin copays at $35 per month for all Medicare beneficiaries. https://t.co/FRyWl5noPt

I am seeing this observational study about GLP-1s reducing death all over the place, and want to note here why I am pretty skeptical of the results. I'd bet there would be an effect on overall mortality, but I doubt it would be this big. The first reason is that we have

We don't know the actual savings Medicare is getting for each drug, because Medicare can't disclose net prices. That's nonsensical. Hospitals and health insurers have to publish negotiated rates (net prices) for everything. Why should drugs be different?

This next story in our @statnews series on UnitedHealth is a doozy: The company has pressed its doctors and clinicians to use a thinly tested medical device to screen people for artery disease, racking up big $ even though many patients were not sick.

We @statnews are out with a new series, Health Care’s Colossus, that examines the ways UnitedHealth Group has accumulated power and exploited it for profit. It has morphed into a modern-day Standard Oil, exerting dominance everywhere in health care.

I've said this before but it bears repeating given how serious and absurd this issue is: There is no greater indictment of the American healthcare system than the reality that it's often cheaper to bypass the entities you pay to get the medical services you need to live

I did this after I was hospitalized for a serious chronic condition. I had decent insurance but changed jobs shortly after that. On an ACA plan, I had to leverage these cracks in the middleman circus. It was the right decision but the system makes it hard even for a health journo

“In England, researchers found that the longer it took someone with COVID-19 to recover from their symptoms, the more that person’s measurable IQ dropped compared with those who never [tested positive],” reports ⁦@the_sy_guy⁩ for ⁦@FastCompany⁩

@EliLillyandCo and @novonordisk revolutionized the weight loss and diabetes drug space. Now, a flood of other GLP-1 drugs are racing to market. @the_sy_guy reports for @FastCompany on the obesity drug arms race

This is one of the greatest Super Bowl half time shows of all time and that’s all I have to say 🔥🔥🔥🔥🔥🔥🔥

Last year, HHS under the direction of SG Vivek Murthy issued an extraordinary directive: Treat loneliness as a public health threat that demands its own kind of medicine. The physical effects of isolation are myriad and manifest:

Biotech is an industry in constant flux between massive upside and daunting risk. I take that to heart: I’m on an Alaska airlines flight from NYC to SF for #JPM RIGHT THIS MOMENT 😤

Let’s meet up if we can at #JPM2024! I get in tomorrow afternoon to SF. In the meantime… https://t.co/giKEMMuNf6

I have no idea if this post will get buried because of the platform on which I’m publishing Phase 5 (this is one reason I’m not here too much anymore) but - sub is free! https://t.co/7YmKdt2TkI

Speaking of - I launched my Phase 5 newsletter right after the new year. For all the deets this LI post is the most detailed account: https://t.co/Er0zGKxIkt And yeah I’m still freelancing for Fast Company on top of this ambitious new venture. Feel free to reach out!